- Home
- AGCC vs SLP Comparison
AGCC vs SLP Comparison
Compare AGCC & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AGCC | SLP |
|---|---|---|
| Founded | 2020 | 1996 |
| Country | Taiwan | United States |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | EDP Services |
| Sector | Consumer Staples | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 209.9M | 248.8M |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | AGCC | SLP |
|---|---|---|
| Price | $19.36 | $12.30 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $25.00 |
| AVG Volume (30 Days) | 63.0K | ★ 352.3K |
| Earning Date | 01-01-0001 | 04-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.03 |
| Revenue | N/A | ★ $59,577,000.00 |
| Revenue This Year | N/A | $2.64 |
| Revenue Next Year | N/A | $6.01 |
| P/E Ratio | ★ $168.97 | $407.00 |
| Revenue Growth | N/A | ★ 10.52 |
| 52 Week Low | $4.23 | $11.16 |
| 52 Week High | $17.73 | $36.43 |
Technical Indicators
Market Signals| Indicator | AGCC | SLP |
|---|---|---|
| Relative Strength Index (RSI) | 78.64 | 35.92 |
| Support Level | $8.61 | $11.16 |
| Resistance Level | N/A | $13.84 |
| Average True Range (ATR) | 2.09 | 0.54 |
| MACD | 0.75 | 0.28 |
| Stochastic Oscillator | 90.27 | 75.49 |
Price Performance
Historical ComparisonAbout AGCC Agencia Comercial Spirits Ltd Class A Ordinary Shares
Agencia Comercial Spirits Ltd specializes in the procurement, distribution, and sale of high-quality whiskies, including both bottled and cask whisky in both Taiwan and international markets. The company's product portfolio includes the distribution of bottled whisky, raw cask whisky, and proprietary brand whisky.
About SLP Simulations Plus Inc.
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.